BHC
Bausch Health Companies Inc
Halal Rating :
Last Price
$7.44
Last updated:
Market Cap
-
7D Change
0.54%
1 Year Change
-9.49%
Company Overview
Industries
Exchange
Next Earnings Date
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals) is a multinational pharmaceutical company that develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices, primarily in the therapeutic areas of eye health, gastroenterology, and dermatology.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $2.51b | $2.54b | - | $346.0m | 0.00% | 13.63% |
| June 30, 2024 | $2.4b | $2.35b | - | $338.0m | 0.00% | 14.37% |
| March 31, 2024 | $2.15b | $2.22b | - | $344.0m | 0.00% | 15.52% |
Company Impact
Help us evaluate Bausch Health Companies Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.